176 related articles for article (PubMed ID: 12818683)
1. Synthesis and biological evaluation of substrate-based inhibitors of 6-phosphogluconate dehydrogenase as potential drugs against African trypanosomiasis.
Dardonville C; Rinaldi E; Hanau S; Barrett MP; Brun R; Gilbert IH
Bioorg Med Chem; 2003 Jul; 11(14):3205-14. PubMed ID: 12818683
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of (R)-2-methyl-4-deoxy and (R)-2-methyl-4,5-dideoxy analogues of 6-phosphogluconate as potential inhibitors of 6-phosphogluconate dehydrogenase.
Dardonville C; Gilbert IH
Org Biomol Chem; 2003 Feb; 1(3):552-9. PubMed ID: 12926259
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high-energy intermediate and transition-state analogues.
Dardonville C; Rinaldi E; Barrett MP; Brun R; Gilbert IH; Hanau S
J Med Chem; 2004 Jun; 47(13):3427-37. PubMed ID: 15189039
[TBL] [Abstract][Full Text] [Related]
4. Sugar derivatives as new 6-phosphogluconate dehydrogenase inhibitors selective for the parasite Trypanosoma brucei.
Pasti C; Rinaldi E; Cervellati C; Dallocchio F; Hardré R; Salmon L; Hanau S
Bioorg Med Chem; 2003 Apr; 11(7):1207-14. PubMed ID: 12628648
[TBL] [Abstract][Full Text] [Related]
5. 6-Phosphogluconate dehydrogenase from Trypanosoma brucei. Kinetic analysis and inhibition by trypanocidal drugs.
Hanau S; Rippa M; Bertelli M; Dallocchio F; Barrett MP
Eur J Biochem; 1996 Sep; 240(3):592-9. PubMed ID: 8856059
[TBL] [Abstract][Full Text] [Related]
6. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design.
Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH
J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646
[TBL] [Abstract][Full Text] [Related]
7. 6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes.
Hanau S; Rinaldi E; Dallocchio F; Gilbert IH; Dardonville C; Adams MJ; Gover S; Barrett MP
Curr Med Chem; 2004 Oct; 11(19):2639-50. PubMed ID: 15544466
[TBL] [Abstract][Full Text] [Related]
8. Virtual fragment screening for novel inhibitors of 6-phosphogluconate dehydrogenase.
Ruda GF; Campbell G; Alibu VP; Barrett MP; Brenk R; Gilbert IH
Bioorg Med Chem; 2010 Jul; 18(14):5056-62. PubMed ID: 20598892
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of a series of melamine-based nitroheterocycles with activity against Trypanosomatid parasites.
Baliani A; Bueno GJ; Stewart ML; Yardley V; Brun R; Barrett MP; Gilbert IH
J Med Chem; 2005 Aug; 48(17):5570-9. PubMed ID: 16107157
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic characterization of substrate and inhibitor binding to Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Montin K; Cervellati C; Dallocchio F; Hanau S
FEBS J; 2007 Dec; 274(24):6426-35. PubMed ID: 18021252
[TBL] [Abstract][Full Text] [Related]
11. Evidence for dimer/tetramer equilibrium in Trypanosoma brucei 6-phosphogluconate dehydrogenase.
Hanau S; d'Empaire LP; Capone I; Alberighi S; Montioli R; Dallocchio F
Biochim Biophys Acta; 2013 Dec; 1834(12):2647-52. PubMed ID: 24096100
[TBL] [Abstract][Full Text] [Related]
12. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
[TBL] [Abstract][Full Text] [Related]
13. Novel inhibitors of Leishmanial dihydrofolate reductase.
Chowdhury SF; Di Lucrezia R; Guerrero RH; Brun R; Goodman J; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
Bioorg Med Chem Lett; 2001 Apr; 11(8):977-80. PubMed ID: 11327604
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
16. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
Croft SL; Snowdon D; Yardley V
J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
[TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of Broad Spectrum Trypanosomatid Selective Inhibitors.
Fraser AL; Menzies SK; King EFB; Tulloch LB; Gould ER; Zacharova MK; Smith TK; Florence GJ
ACS Infect Dis; 2018 Apr; 4(4):560-567. PubMed ID: 29313667
[TBL] [Abstract][Full Text] [Related]
18. 6-Phosphogluconate dehydrogenase: the mechanism of action investigated by a comparison of the enzyme from different species.
Rippa M; Giovannini PP; Barrett MP; Dallocchio F; Hanau S
Biochim Biophys Acta; 1998 Dec; 1429(1):83-92. PubMed ID: 9920387
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Chowdhury SF; Villamor VB; Guerrero RH; Leal I; Brun R; Croft SL; Goodman JM; Maes L; Ruiz-Perez LM; Pacanowska DG; Gilbert IH
J Med Chem; 1999 Oct; 42(21):4300-12. PubMed ID: 10543874
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of (2,2':6',2''-terpyridine)platinum(II) complexes to Leishmania donovani, Trypanosoma cruzi, and Trypanosoma brucei.
Lowe G; Droz AS; Vilaivan T; Weaver GW; Tweedale L; Pratt JM; Rock P; Yardley V; Croft SL
J Med Chem; 1999 Mar; 42(6):999-1006. PubMed ID: 10090783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
